TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

Barbara Davis Center

Aurora, Colorado, United States, 80045

Contact: Lexie Chesshir, RN    303-724-1755    lexie.chesshir@cuanschutz.edu   

Principal Investigator: Kimber Simmons, MD         

University of Chicago

Chicago, Illinois, United States, 60637

Contact: Triniece Pearson, PhD,RN    773-359-7556    tpearson1@medicine.bsd.uchicago.edu   

Principal Investigator: Siri Greeley, MD         

IU Health Riley Hospital for Children

Indianapolis, Indiana, United States, 46202

Contact: Ellie M Ryan    317-278-7037    elmryan@iu.edu   

Contact: T1D Research    317-278-8879    tadpol@iu.edu   

Principal Investigator: Emily K Sims, MD, MS         

Sub-Investigator: Linda A DiMeglio, MD, MPH         

Children’s Mercy Hospital

Kansas City, Kansas, United States, 64108

Contact: Heather Harding, RN         

Principal Investigator: Mark Clements, MD, PhD         

University of Michigan

Ann Arbor, Michigan, United States, 48109

Contact: Sheree Nicholson    734-232-4213    nsheree@med.umich.edu   

Principal Investigator: Inas Thomas, MD         

Medical College of Wisconsin

Milwaukee, Wisconsin, United States, 53226

Contact: Joanne Kramer, BS    414-955-8486    jkramer@mcw.edu   

Principal Investigator: Susanne Cabrera, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 29, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments